References in periodicals archive ?
Frequency of study variables in different groups of study subjects Variables Total Total anti- (n=173) HBcAb (n=15) Age (years) 39.2 [+ or -] 10.6 39.26 [+ or -] 9.7 Male 151(87.3%) 14(9.27%) Female 22(22.7%) 1(4.5%) H/O Jaundice 19(10.9%) 2(10.5%) Hospitalization 24(13.8%) 4(16.7%) IV infusion 24(13.8%) 4(16.7%) Surgery 17(9.8%) 2(11.7%) Blood transfusion 5(2.9%) 2(40%) Frequent injections 5(2.9%) 2(40%) G.
The high rates of immunity (57.2%) among children without past infection with HBV (HBcAb negative) supports the value of overseas immunization programs, including the WHO Expanded Programme on Immunization and the CDC-Bureau of Population, Refugees, and Migration (U.S.
We assessed serological tests of HBsAg, HBsAb, HBeAg, HBeAb, HBcAb, and anti-HCV using Architect chemiluminescent enzyme immunoassays (Abbott Architect i system).
Group-3 (immune due to hepatitis B vaccination): HBsAg, HBcAb (IgG) were found negative with positive HBsAb;
19.2.5 Prevention of hepatitis B following the transplantation of livers from donors who are HBsAg negative and IgG HBcAb positive
All specimens had been subjected to a full primary screen for HBV disease status, which consisted of HBV surface antigen (HBsAg), total core antibody (HBcAb IgM and IgG) and antibody to surface antigen (HBsAb).
The second Italian Liver Match cohort study, evaluated the survival of liver grafts from HBcAb+ve donors in patients (recipients) with hepatitis, by analysing data from 1477 adult liver transplantations from June 2007 to May 2009.Of these, 1237 were HBcAb negative and 240 HBcAb positive donors, with unadjusted two-year graft survival of 80 and 69 percent respectively.
Springer, medical director of the International Adoption Health Services of Western Pennsylvania, recommended a wide range of lab tests, including a CBC, lead level, stool test for ova and parasite (O&P) (3), rapid plasma regain (RPR) or VDRL (Venereal Disease Research Laboratory) tests for syphilis, hepatitis B surface antigen (HBsAg), hepatitis B surface antibody (HbsAb), hepatitis B core antibody (HbcAb), hepatitis C virus (HCV), HIV-1 and HIV-2, a tuberculin skin test (PPD), or an interferon gamma release assay (IGRA) test if the child is older than 5 years of age.
Acutely infected patients who do not develop chronic hepatitis B will become hepatitis B surface antigen (HBsAg)-negative, hepatitis B core antibody (HBcAb)-positive, and HBsAb (anti-HBs)-positive.
Of those who did not have sole HCV testing, 4% were positive for hepatitis B surface antigen (HBsAg), whereas 39% were positive for hepatitis B core antibody (HBcAb), and 22% were positive for hepatitis B surface antibody (HBsAb).
Serological evidence of current or previous Hepatitis B virus infection (HBsAg positive and/or HBcAb positive) was seen in 29% of patients (Table III), and this did not vary with age.
The HBsAg and Hepatitis B core antibody (HBcAb) status of an organ donor or recipient determine the risk of infection and transmission of HBV following transplantation.
Acronyms browser ?
Full browser ?